TE_169
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | SVA_D, AluSc8 |
|---|---|
| TE superfamily | Alu, SVA |
| TE class | Retroposon, SINE |
| Gene | SDHB |
| Class | Chimeric |
| Coding | Non-coding, Other |
| Tumor-specific score | 24.96 |
| Counts of samples | TCGA_tumor:154; TCGA_normal:6; GTEx:0 |
| TSS | chr1(-):17029533 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_169.1 | SDHB | Chimeric | Non-coding | Non-coding | chr1(-):17018938,17018958,17022608,17022730,17023973,17024074,17027749,17027865,17028600,17028736,17029419,17029534 |
| teRNA_169.2 | SDHB | Chimeric | Non-coding | Non-coding | chr1(-):17018938,17018958,17022608,17022730,17023973,17024074,17027760,17027865,17028600,17028736,17029419,17029534 |
| teRNA_169.3 | SDHB | Chimeric | Non-coding | Non-coding | chr1(-):17018938,17018958,17022608,17022730,17023973,17024074,17027793,17027865,17028600,17028736,17029419,17029534 |
| teRNA_169.4 | SDHB | Chimeric | Non-coding | Non-coding | chr1(-):17018938,17018958,17022608,17022730,17023973,17024074,17027749,17027865,17028654,17028736,17029419,17029534 |
| teRNA_169.5 | SDHB | Chimeric | Non-coding | Non-coding | chr1(-):17018938,17018958,17022608,17022730,17023973,17024074,17028654,17028736,17029419,17029534 |
| teRNA_169.6 | SDHB | Chimeric | Other | MNINGGNTLACTRRIDTNLNKVSKIYPLPHMYVIKDLVPDLSNFYAQYKSIEPYLKKKDESQEGKQQYLQSIEEREKLDGLYECILCACCSTSCPSYWWNGDKYLGPAVLMQVRCSLIALREIETQASRSPRGQ* | chr1(-):17018938,17018958,17022608,17022730,17023841,17024074,17027749,17027865,17028600,17028736,17029419,17029534 |
| teRNA_169.7 | SDHB | Chimeric | Non-coding | Non-coding | chr1(-):17018938,17018958,17027749,17027865,17028600,17028736,17029419,17029534 |
| teRNA_169.8 | SDHB | Chimeric | Non-coding | Non-coding | chr1(-):17027845,17027865,17028600,17028736,17029419,17029534 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
